Marc Zumberg, M.D.

Marc S Zumberg, M.D.

(352) 265-8199

Request an Appointment

Publications

Systems-based hematology: highlighting successes and next steps.
Blood advances
2020

Bleeding and Thrombotic Risk in Low Dose Heparin Infusion as Compared to Standard Dose Heparin Infusion.
Cureus
2020

A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.
Transfusion
2020

Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
Transfusion
2019

Update in Hematology and Oncology: Evidence Published in 2016.
Annals of internal medicine
2017

A Patient-Centered Emergency Department Management Strategy for Sickle-Cell Disease Super-Utilizers.
The western journal of emergency medicine
2017

Patient satisfaction with extended-interval warfarin monitoring.
Journal of thrombosis and thrombolysis
2016

Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.
BMJ case reports
2016

Successful implementation of a packed red blood cell and fresh frozen plasma transfusion protocol in the surgical intensive care unit.
PloS one
2015

Steps to diagnosis of a case of surreptitious intake of one of the newer direct oral anticoagulants: a case report and literature review.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
2015

Reply: clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.
The Annals of pharmacotherapy
2015

Preclinical Medical Student Hematology/Oncology Education Environment.
Journal of cancer education : the official journal of the American Association for Cancer Education
2015

Feasibility of Extended-interval Follow-up for Patients Receiving Warfarin.
Cardiovascular therapeutics
2015

Myelodysplastic syndrome and associated coagulopathy: a case report and review.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
2014

Hemophilia C in a Patient Undergoing Cardiac Surgery: Perioperative Considerations.
Seminars in cardiothoracic and vascular anesthesia
2014

Successful Implementation of a Packed Red Blood Cell and Fresh Frozen Plasma Transfusion Protocol in the Surgical Intensive Care Unit
Critical Care Medicine
2012

Intentional low-molecular-weight heparin overdose: a case report and review.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
2012

A case series of atypical presentations of thrombotic thrombocytopenic purpura.
Journal of clinical apheresis
2012

Labor and delivery in a patient with hemophilia B.
International journal of obstetric anesthesia
2011

Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
The Annals of pharmacotherapy
2011

The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
Journal of pharmacy practice
2010

Sirolimus-induced severe hypertriglyceridemia in a lung transplant recipient.
Transplantation
2010

A Massive Pulmonary Embolism Treatment Protocol: How Trauma Performance Improvement Affects Outcome Throughout the Hospital System
The American Surgeon
2010

A Massive Pulmonary Embolism Treatment Protocol: How Trauma Performance Improvement Affects Outcome Throughout the Hospital System
The American Surgeon
2010

Efficiency of a Weight-Based Low-Intensity Heparin Protocol for Patients Considered At High Risk for Bleeding
Critical Care Medicine
2009

Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature.
American journal of hematology
2007

Acute liver failure occurring immediately following anti-D immune globulin infusion in a patient with chronic hepatitis B infection.
Digestive diseases and sciences
2007

Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.
American journal of hematology
2005

A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
Chest
2005

Role of phlebotomy in the management of hemoglobin SC disease: case report and review of the literature.
American journal of hematology
2003

GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation.
Cytotherapy
2002

A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2002

Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure.
Thrombosis and haemostasis
2001

Cesarean section combined with splenectomy in a parturient with immune thrombocytopenic purpura.
Journal of clinical anesthesia
2001

Autoantibody formation in the alloimmunized red blood cell recipient: clinical and laboratory implications.
Archives of internal medicine
2001

Management of a patient with a mechanical aortic valve and antibodies to both thrombin and factor V after repeat exposure to fibrin sealant.
American journal of hematology
2000

Inclusive education in Finland: present and future perspectives.
Psychological reports
1994

Research Interests

  • Dr. Zumberg's intersts center around benign hematology and include ITP, HIT and Anemia.
  • Dr. Zumberg spends the majority of his time as a attending physician on the inpatient hematology consultation service at Shands Hospital. Dr. Zumberg also provides outpatient, new patient, and follow-up services at the outpatient Davis Cancer Center. He serves as the Medical Director of Therapeutic Apheresis for Lifesouth, the region's blood provider. He is also the Medical Director for the Shands-UF Outpatient Anticoagulation Clinic. He serves as Chairman for the Transfusion Committee at Shands Hospital. His research interests are in ITP, sickle cell disease, and other areas of benign hematology.